reason report
eye upcom decis unbundl exparel
asc pt
look good expand ambulatori surgic center
opportun two month away assum
propos get approv soon exparel grew y/i even
show growth q/q nerv block opportun continu take
shape op collabor provid tailwind
rais exparel sale estim due factor
estim within manag revis guidanc rang
top propos unbundl
asc begin januari could drive upsid
estim final decis impend rais
price target slightli reflect improv outlook
exparel near-term growth opportun exparel continu
look promis still believ exparel growth outer year could
pressur due competit heron op
manag provid preliminari color potenti impact
exparel unbundl set manag note
take time build awar get contract place
would unreason contempl benefit rang
unbundl exparel regain volum
set c-code fact manag also note
could upsid increas mix surgeri
chang model rais exparel sale
estim lower end manag
revis guidanc rang overal posit view
trajectori add exparel sale estim go
forward chang exparel result increas pt
dcf use wacc
termin growth rate
net debt total capit
per share inlud short-term
compani inform leerink partner llc research
revenu
pleas refer page import disclosur price chart analyst certif
believ pacira exparel non-opioid post-op pain manag continu
grow driven commerci collabor sale
believ well understood investor long-term growth may impact
entri heron better clinic profil -- longer durat pain relief hour vs
hour easier administr instil vs infiltr note signific upsid
potenti exist exparel unbundl note appear recept
recent propos ambulatori surgic center kick start howev limit
visibl magnitud impact could rate pacira stock market perform
mp price target
pt base dcf forecast cash flow use
wacc termin growth rate
phase iv studi success limit impact collabor potenti competit
heron
note number
exparel net product gross sg guidancerevis guidancerevis producttop indicationev detailsd rangeexparelpost-op pain final decis unbundl payment exparel acut postsurg paindecis initi phase pacira pharmaceut inc
figur chang model
lp estim note number except ep
note revenu
varianc analysisleerink partnersami fadiaconfer call analystdi changevalu changevarianceconsensusactu vs constherapeut product licens mileston earli extinguish dilut non-gaap adjustmentstot one-tim net inc
number except per share data
net debt ebitda ratio
figur except per share data
collabor licens develop revenu
sourc press releas transcript sec file
number except per share data
prepaid expens
current portion defrer revenu
accumul comprehens loss
number except per share data
adjust reconcil ni net cash oper
amort unfavor leas oblig debt issuanc cost
amort debt discount
loss dispos fix asset
loss extinguish debt
decreas increas work capit
purchas fix asset capital-expenditure
purchas invest
sale invest
payment conting consider
net invest
proce exercis stock option warrant
proce share issu employe stock purchas plan
convers princip equiti compon convert senior
net financ
net chang equival
